Table 4.

Distribution of COVID-19 outcomes according to the individual variables selected

Variables	Death		Non-death		Statistic parameter	P-value
	n	%	n	%	Chi-square
Age group					40,056	0.000
0–9 years	60	0,3%	5045	2.2%	–	–
10–19 years	34	0,2%	7444	3.3%	–	–
20–29 years	210	1,2%	30,216	13.4%	–	–
30–39 years	603	3,3%	53,051	23.5%	–	–
40–49 years	1400	7,7%	50,513	22.4%	–	–
50–59 years	2526	14,0%	38,203	16.9%	–	–
60–69 years	4154	23,0%	22,880	10.1%	–	–
70–79 years	4425	24,5%	10,848	4.8%	–	–
80 years or older	4622	25,6%	6190	2.7%	–	–
Sex					521	0.000
Female	8003	44,3%	119,674	53.1%	–	–
Male	10,073	55,7%	105,759	46.9%	–	–
Race/color					794	0.000
Brown	4480	24,8%	75,682	33.6%	–	–
Asian	182	1,0%	11,693	5.2%	–	–
White	5041	27,9%	74,454	33.0%	–	–
Indigenous	11	0,1%	480	0.2%	–	–
Black	1479	8,2%	14,323	6.4%	–	–
Missing	6883	38,08%	48,801	21.6%	–	–
Presence of signs and symptoms					–	–
Fever	8723	48,3%	84,379	37.4%	830	0.000
Cough	8908	49,3%	99,526	44.1%	178	0.000
Headache	503	2,8%	32,517	14.4%	1934	0.000
Sneezing	10	0,1%	1626	0.7%	110	0.000
Odynophagia	1560	8,6%	41,237	18.3%	1078	0.000
Dyspnea	10,204	56,5%	42,172	18.7%	14,118	0.000
Runny nose	233	1,3%	17,906	7.9%	1074	0.000
Diarrhea	143	0,8%	12,658	5.6%	781	0.000
Muscle pain	803	4,4%	22,212	9.9%	571	0.000
Loss of smell	194	1,1%	21,570	9.6%	1483	0.000
Loss of taste	99	0,5%	15,379	6.8%	1106	0.000
Presence of comorbidities					–	–
Cardiovascular disease	6163	34,1%	19,682	8.7%	21,646	0.000
Diabetes mellitus	4341	24,0%	11,159	5.0%	26,588	0.000
Chronic kidney disease	923	5,1%	1280	0.6%	11,461	0.000
Chronic respiratory disease	845	4,7%	5473	2.4%	346	0.000
Immunodeficiency/ immunosuppression	464	2,6%	2063	0.9%	2153	0.000
Total	18,076	7,4%	225,433	92.6%	–	–

Note: confirmed cases of COVID-19, state of Rio de Janeiro, March–September 2020